The Impact Review – Founding Vibe Bio
The Impact Review article explores Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases.
News
STAT – Upending drug industry financing
This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing.
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.
Endpoint News – Parents become drug developers to save their children’s lives
Endpoint News addressed how parents of children with rare disease are challenging the status quo in drug development.
Coindesk – How Vibe Bio plans to retool biotech funding
In this article, Vibe Bio founder and CEO, Alok Tayi, explains how a decentralized science approach can retool biotech funding.
The Scoop – A conversation with Alok Tayi
“In this episode of The Scoop, Tayi shares his vision for how Vibe Bio aims to disrupt the centralized control of big pharma”